4//SEC Filing
James Andrea S. 4
Accession 0001493152-25-020719
CIK 0001642380other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:05 PM ET
Size
8.1 KB
Accession
0001493152-25-020719
Insider Transaction Report
Form 4
James Andrea S.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-31+50,000→ 201,231 total - Disposition to Issuer
Restricted Stock Units
2025-10-31+50,000→ 50,000 total→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Represents an award of performance-based restricted stock units ("RSUs") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of Common Stock.
- [F2]The RSUs vested on the last day of the month upon satisfaction of the "Baby Shelf" performance condition described in the Reporting Person's Employment Agreement, which required that the Company's public float reach at least $75 million such that the Company would no longer be subject to the SEC's "baby shelf" limitations on Form S-3 eligibility. The satisfaction of this condition resulted in the vesting of 50% of the RSUs granted to the Reporting Person, subject to the Reporting Person's continued service.
Documents
Issuer
Insight Molecular Diagnostics Inc.
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0002027010
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 4:05 PM ET
- Size
- 8.1 KB